Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Placebos in Argentina
Total 0 results
Nothing found
Sponsors and Collaborators
Aliae AR Mohamed Hussein [ahussein
Xinjiang Uygur Pharmaceutical Co., Ltd.
ACS Biomarker
New Area People's Hospital of Luoyang
UNICEF Sri Lanka
Big Leap Clinical Research Joint Stock Company
Hämeen Liikunta ja Urheilu ry
Dong-Eui University
LLC Merck, Russia
Zhuhai Tonbridge Medical Tech. Co., Ltd.
American Association for Hand Surgery: AAHS
Gary E. Ruoff, M.D.
NuVasive
YaNi Peng
shuai Mao
M3-Wake Research Associates
Perseverance Research Center, LLC
Joseph Adame
Lohmann und Birkner medizinisches ServiceCenter GmbH
Dalin Tzu Chi General Hospital
View Full List
Medical Conditions
Kratom Pharmacokinetics
Medical Trainees in Oncology Programs
Rupture of Tendon of Wrist and Hand
Anemia in Incident Dialysis Patients
Post- Essential Thrombocythemia Myelofibrosis
Fibrolamellar Liver Cancer
Rate of PSA Response in Oligometastatic,CRPC Undergoing SBRT in Combination With Abiraterone Acetate (AA), Compared to Patients Treated With AA Alone
Sedated
Thyroid Disfunction
Other Developmental Pervasive Disorder
COVID-19, SARS-CoV-2 Infection
Diabetic Ulcers in Necrosis Stable Stage
BRCA1 Gene
MAJOR DEPRESSIVE DISORDER
Withdrawing Treatment
Euvolemia
NSAID-Associated Gastropathy
Gastric Outlet Obstruction Due to Malignancy
Unstable Angina (Intermediate Coronary Syndrome)
Whole Body Protein Metabolism
View Full List
Drug Interventions
Metoclopramide 10 mg
Amoxicillin, levofloxacin, ofloxacin, sulfamethoxazole/trimethoprim
0.15% azelastine hydrochloride
Ranitidine (or equivalent)
Norepinephrine
Liposomal doxorubicin
Losec
Cohort B: ORMD-0801
Chemotherapy (nab-paclitaxel AUC=2 and carboplatin 80mg/m2),Immunotherapy (camrelizumab 200mg)、Radiotherapy(primary lesion and adjacent lymph nodes 41.4Gy, distant lymph node 0.5Gy*4)
Methylnaltrexone bromide
Medium-dose ZKY001 eye drops
Tocilizumab Injection
Double-Blind Rituximab
Botulin toxin
Topiramate
Lipoic acid
Fludarabine Injection
Linifanib
Filgotinib
HB0036
View Full List
CROs by country
Contract Research Organizations in Bosnia & Herzegovina
Contract Research Organizations in Costa Rica
Contract Research Organizations in El Salvador
Contract Research Organizations in Ethiopia
Contract Research Organizations in Hong Kong
Contract Research Organizations in Iran
Contract Research Organizations in Kyrgyzstan
Contract Research Organizations in Mauritania
Contract Research Organizations in Mexico
Contract Research Organizations in Philippines
Contract Research Organizations in Saudi Arabia
Contract Research Organizations in Tanzania
Contract Research Organizations in Ukraine
CRO list by country
CROs in Japan
Biotoxtech CRO
KRI, Inc. (Kansai Research Institute)
SGS
Bio Reliance Corporation
Clinlogix
Parexel
Syneos Health
PPD
CMIC Group
FALCO Biosystems
All CROs in Japan
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe